On 12 and 13 September, the 12th International VPM Days took place at TWINCORE in Hannover. More than 20 international speakers and almost 100 visitors accepted the invitation of Vakzine Projekt Management GmbH (VPM).
TBVI (TuBerculosis Vaccine Initiative) Annual Symposium 2019
VPM was invited to join the TBVI (TuBerculosis Vaccine Initiative) Annual Symposium which was held on 29th of January until 31th of January 2019 in Les Diablerets, Switzerland.
priMe Consortium Kick-Off Meeting
From 28. to 29.11.2018, VPM organized a kick off meeting in Johannesburg, South Africa, for a pivotal VPM1002 phase III trial to be conducted in newborn infants in South Africa, Tanzania, Kenya, Uganda and Gabon.
2018 PDA Europe Vaccines
VPM will speak during the 2018 PDA Europe Vaccines conference in Malaga, Spain that will take place from 24. to 25.04.2018.
EAU18 Copenhagen
Erste Ergebnisse der klinischen Phase I/II Studie zur Untersuchung des neuen Medikaments VPM1002BC werden auf dem internationalen Kongress der European Association of Urology 2018 in Kopenhagen, Dänemark vom 16.-20. März präsentiert.
CMV2017 in Noordwijkerhout, The Netherlands
VPM will be present at the 6th International Congenital CMV Conference / 16th International CMV/betaherpesvirus Workshop in Noordwiijkerhout, the Netherlands from Mar 30 to May 4 2017.
Press reviews on tuberculosis vaccine VPM1002
In due of the progressing clinical testing of VPM1002 as a vaccine against tuberculosis, Indian news media The Hindu report on VPM1002.